Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

Forecast Balance Sheet - Procter & Gamble Company
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 24,279 26,361 22,978 24,952 24,196 25,651 24,334 22,196
Change - 8.58% -12.83% 8.59% -3.03% 6.01% -5.13% -8.79%
Announcement Date 29/07/22 28/07/23 30/07/24 29/07/25 29/07/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 3,156 3,062 3,322 3,773 4,409 4,447 4,164 4,198
Change - -2.98% 8.49% 13.58% 16.86% 0.87% -6.37% 0.81%
Free Cash Flow (FCF) 1 13,567 13,786 16,524 14,606 15,147 15,462 16,743 17,862
Change - 1.61% 19.86% -11.61% 3.7% 2.08% 8.29% 6.68%
Announcement Date 29/07/22 28/07/23 30/07/24 29/07/25 29/07/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 25.71% 25.42% 27.23% 27.65% 27.18% 27.31% 27.83% 28.03%
EBIT Margin (%) 22.21% 22.11% 23.78% 24.27% 23.55% 23.57% 23.99% 24.2%
EBT Margin (%) 22.44% 22.38% 22.32% 23.93% 23.41% 23.51% 24.15% 23.91%
Net margin (%) 18.38% 17.87% 17.7% 18.95% 18.44% 18.22% 18.92% 18.99%
FCF margin (%) 16.92% 16.81% 19.66% 17.33% 17.4% 17.23% 18.1% 18.64%
FCF / Net Income (%) 92.03% 94.08% 111.06% 91.44% 94.4% 94.57% 95.65% 98.13%

Profitability

        
ROA 12.47% 12.31% 13.39% 12.9% 12.75% 12.73% 13.15% 13.47%
ROE 31.53% 31.2% 30.48% 31.06% 30.11% 30.27% 31.21% 31.67%

Financial Health

        
Leverage (Debt/EBITDA) 1.18x 1.26x 1x 1.07x 1.02x 1.05x 0.95x 0.83x
Debt / Free cash flow 1.79x 1.91x 1.39x 1.71x 1.6x 1.66x 1.45x 1.24x

Capital Intensity

        
CAPEX / Current Assets (%) 3.94% 3.73% 3.95% 4.48% 5.07% 4.96% 4.5% 4.38%
CAPEX / EBITDA (%) 15.31% 14.69% 14.52% 16.19% 18.64% 18.15% 16.17% 15.63%
CAPEX / FCF (%) 23.26% 22.21% 20.1% 25.83% 29.11% 28.76% 24.87% 23.5%

Items per share

        
Cash flow per share 1 6.586 6.783 8.029 7.259 8.073 8.355 9.208 9.682
Change - 2.99% 18.37% -9.58% 11.21% 3.49% 10.22% 5.15%
Dividend per Share 1 3.523 3.681 3.829 4.076 4.259 4.403 4.603 4.823
Change - 4.47% 4.02% 6.47% 4.48% 3.37% 4.56% 4.77%
Book Value Per Share 1 19.57 19.8 20.45 21.3 22.42 23.87 24.92 26.3
Change - 1.18% 3.28% 4.15% 5.24% 6.45% 4.42% 5.54%
EPS 1 5.81 5.9 6.02 6.51 6.62 6.815 7.36 7.712
Change - 1.55% 2.03% 8.14% 1.69% 2.94% 8.01% 4.77%
Nbr of stocks (in thousands) 2,399,297 2,356,969 2,360,135 2,344,542 2,328,599 2,317,783 2,317,783 2,317,783
Announcement Date 29/07/22 28/07/23 30/07/24 29/07/25 29/07/26 - - -
1USD
Estimates
2027 *2028 *
P/E 23.2x 21.5x
PBR 6.63x 6.35x
EV / Sales 4.37x 4.23x
Yield 2.78% 2.91%

EPS & Dividend

EPS & Dividend - Procter & Gamble Company


Y-o-Y evolution of P/E

Valuation ratios - P/E - Procter & Gamble Company
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Procter & Gamble Company
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Procter & Gamble Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
158.26USD
Average target price
173.30USD
Spread / Average Target
+9.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Procter & Gamble Company
  1. Stock Market
  2. Stocks
  3. PG Stock
  4. Financials Procter & Gamble Company